Viewing Study NCT00478660


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-01-07 @ 3:54 AM
Study NCT ID: NCT00478660
Status: COMPLETED
Last Update Posted: 2007-10-10
First Post: 2007-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
Sponsor: Abbott
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module